Clinical trial
Validation of a Novel, Minimally Invasive Ultrasound Indicator Dilution Technique for Measuring Cardiac Index in Critically Ill Children
NCT00852254 is registered in ClinicalTrials.gov with Transonic Systems Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Validation of a Novel, Minimally Invasive Ultrasound Indicator Dilution Technique for Measuring Cardiac Index in Critically Ill Children
- Lead sponsor
- Transonic Systems Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- May 31, 2011
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac output